Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cellsTomotaka Kato, Minoru Tanabe, Mikiya Fujii et al.|PLoS ONE|2021Cited by 30